The COVID-19 pandemic has touched nearly every part of our lives, and the universal impact has been astounding. The result has undoubtedly created a shock across Clinical Trials teams around the globe. Research teams are now facing new, often difficult decisions regarding the progress of their studies and the safety of their team members.
We acknowledge that this is impacting our field and our partners, but we are also keenly aware that there is an opportunity for innovation! To serve our community, we have reached out to four thought leaders in the industry to see how they have taken to adapting to Clinical Trial research in the age of COVID-19.
These organizations are leveraging remote technology to mitigate disruptions to their systems, policies, and processes necessary to continue in safe, regulated studies.